Vascular Effects of Eplerenone in Coronary Artery Disease With Preserved Ejection Fraction: A Double-Blind, Randomized, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Vascular Effects of Eplerenone in Coronary Artery Disease With Preserved Ejection Fraction: A Double-Blind, Randomized, Placebo-Controlled Trial

Published:2016-03-14 Issue:5 Volume:39 Page:285-290
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Sudano Isabella¹,Naegele Matthias¹,Roas Susanne¹,Périat Daniel¹,Frank Michelle¹,Kouroedov Alexey²,Noll Georg¹²,Lüscher Thomas F.¹²,Enseleit Frank¹,Ruschitzka Frank¹²,Flammer Andreas J.¹

Affiliation:

1. University Heart Center, Cardiology Clinic; University Hospital Zurich; Zurich Switzerland

2. Center for Integrative Human Physiology; University of Zurich; Zurich Switzerland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference25 articles.

1. The effect of spironolactone on morbidity and mortality in patients with severe heart failure;Pitt;N Engl J Med,1999

2. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [published correction appears in N Engl J Med. 2003;348:2271];Pitt;N Engl J Med,2003

3. Spironolactone for heart failure with preserved ejection fraction;Pitt;N Engl J Med,2014

4. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure;Güder;Circulation.,2007

5. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure;Ivanes;Eur Heart J.,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of mineralocorticoid receptor antagonists on cardiovascular outcomes in patients with end‐stage renal disease and heart failure;European Journal of Heart Failure;2022-12-11

2. Effect of Mineralocorticoid Receptor Blockade on Arterial Stiffness and Endothelial Function;Hypertension;2021-03-03

3. Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches;Current Medicinal Chemistry;2020-03-16

4. Mineralocorticoid Receptor Antagonists in the Treatment of Coronary Artery Disease, Myocardial Infarction and Heart Failure;Aldosterone-Mineralocorticoid Receptor - Cell Biology to Translational Medicine;2019-09-25

5. Efficacy of mineralocorticoid receptor antagonists in postmyocardial infarction patients with or without left ventricular dysfunction;Medicine;2018-12